{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "modelUsed": "gemini-3-flash-preview",
  "narrative": {
    "narrativeContents": [
      {
        "id": "nc_1",
        "name": "PROTOCOL SUMMARY",
        "text": "PROTOCOL SUMMARY",
        "order": 0,
        "instanceType": "NarrativeContent",
        "sectionNumber": "N/A",
        "sectionTitle": "PROTOCOL SUMMARY",
        "sectionType": {
          "id": "def0a347-c992-441d-b616-4b6ac5b549d2",
          "code": "Synopsis",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Synopsis",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_2",
        "name": "SCHEDULE OF ACTIVITIES FOR RUN-IN AND BLINDED TREATMENTS",
        "text": "SCHEDULE OF ACTIVITIES FOR RUN-IN AND BLINDED TREATMENTS",
        "order": 1,
        "instanceType": "NarrativeContent",
        "sectionNumber": "N/A",
        "sectionTitle": "SCHEDULE OF ACTIVITIES FOR RUN-IN AND BLINDED TREATMENTS",
        "sectionType": {
          "id": "6c639bd7-7462-42e5-b8de-982dae482599",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_3",
        "name": "SCHEDULE OF ACTIVITIES FOR RESCUE TREATMENT – FLARE AT SCHEDULED OR UNSCHEDULED VISIT",
        "text": "SCHEDULE OF ACTIVITIES FOR RESCUE TREATMENT – FLARE AT SCHEDULED OR UNSCHEDULED VISIT",
        "order": 2,
        "instanceType": "NarrativeContent",
        "sectionNumber": "N/A",
        "sectionTitle": "SCHEDULE OF ACTIVITIES FOR RESCUE TREATMENT – FLARE AT SCHEDULED OR UNSCHEDULED VISIT",
        "sectionType": {
          "id": "4cb5ecf7-6e99-4246-9230-d6613eebf226",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_4",
        "name": "INTRODUCTION",
        "text": "INTRODUCTION",
        "order": 3,
        "instanceType": "NarrativeContent",
        "sectionNumber": "1",
        "sectionTitle": "INTRODUCTION",
        "sectionType": {
          "id": "239066ad-8c4e-4831-b578-0932c041b6a4",
          "code": "Introduction",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Introduction",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_4_1",
          "nci_4_2",
          "nci_4_3",
          "nci_4_4",
          "nci_4_5",
          "nci_4_6"
        ]
      },
      {
        "id": "nc_5",
        "name": "STUDY OBJECTIVES AND ENDPOINTS",
        "text": "STUDY OBJECTIVES AND ENDPOINTS",
        "order": 4,
        "instanceType": "NarrativeContent",
        "sectionNumber": "2",
        "sectionTitle": "STUDY OBJECTIVES AND ENDPOINTS",
        "sectionType": {
          "id": "30e3ea7b-8b9b-4b35-b4d1-c50f608aac02",
          "code": "Objectives",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Objectives",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_6",
        "name": "STUDY DESIGN",
        "text": "STUDY DESIGN",
        "order": 5,
        "instanceType": "NarrativeContent",
        "sectionNumber": "3",
        "sectionTitle": "STUDY DESIGN",
        "sectionType": {
          "id": "d036f680-6178-40f7-9d82-51a197eb2272",
          "code": "Study Design",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Design",
          "instanceType": "Code"
        }
      },
      {
        "id": "nc_7",
        "name": "SUBJECT ELIGIBILITY CRITERIA",
        "text": "SUBJECT ELIGIBILITY CRITERIA",
        "order": 6,
        "instanceType": "NarrativeContent",
        "sectionNumber": "4",
        "sectionTitle": "SUBJECT ELIGIBILITY CRITERIA",
        "sectionType": {
          "id": "2893b9f1-9330-406f-9b63-e92afb73aa64",
          "code": "Eligibility Criteria",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Eligibility Criteria",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_7_1",
          "nci_7_2",
          "nci_7_3",
          "nci_7_4",
          "nci_7_5"
        ]
      },
      {
        "id": "nc_8",
        "name": "STUDY TREATMENTS",
        "text": "STUDY TREATMENTS",
        "order": 7,
        "instanceType": "NarrativeContent",
        "sectionNumber": "5",
        "sectionTitle": "STUDY TREATMENTS",
        "sectionType": {
          "id": "5a4ab5b4-29c2-4336-a17d-a4bd4909c90a",
          "code": "Treatment",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Treatment",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_8_1",
          "nci_8_2",
          "nci_8_3",
          "nci_8_4",
          "nci_8_5",
          "nci_8_6",
          "nci_8_7",
          "nci_8_8",
          "nci_8_9"
        ]
      },
      {
        "id": "nc_9",
        "name": "STUDY PROCEDURES",
        "text": "STUDY PROCEDURES",
        "order": 8,
        "instanceType": "NarrativeContent",
        "sectionNumber": "6",
        "sectionTitle": "STUDY PROCEDURES",
        "sectionType": {
          "id": "c918a0fa-ec00-4c55-b0ac-bf7b19d70f00",
          "code": "Study Procedures",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Study Procedures",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_9_1",
          "nci_9_2",
          "nci_9_3",
          "nci_9_4",
          "nci_9_5",
          "nci_9_6"
        ]
      },
      {
        "id": "nc_10",
        "name": "ASSESSMENTS",
        "text": "ASSESSMENTS",
        "order": 9,
        "instanceType": "NarrativeContent",
        "sectionNumber": "7",
        "sectionTitle": "ASSESSMENTS",
        "sectionType": {
          "id": "4d13bc4b-25b3-41b9-af56-6f389aa589e4",
          "code": "Assessments",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Assessments",
          "instanceType": "Code"
        },
        "childIds": [
          "nci_10_1",
          "nci_10_2",
          "nci_10_3",
          "nci_10_4"
        ]
      }
    ],
    "narrativeContentItems": [
      {
        "id": "nci_4_1",
        "name": "Mechanism of Action/Indication",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.1",
        "sectionTitle": "Mechanism of Action/Indication"
      },
      {
        "id": "nci_4_2",
        "name": "Background and Rationale",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.2",
        "sectionTitle": "Background and Rationale"
      },
      {
        "id": "nci_4_3",
        "name": "Summary of PF-04965842 Clinical Pharmacokinetics",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.3",
        "sectionTitle": "Summary of PF-04965842 Clinical Pharmacokinetics"
      },
      {
        "id": "nci_4_4",
        "name": "Population Pharmacokinetics",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.4",
        "sectionTitle": "Population Pharmacokinetics"
      },
      {
        "id": "nci_4_5",
        "name": "Summary of Benefits and Risks",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.5",
        "sectionTitle": "Summary of Benefits and Risks"
      },
      {
        "id": "nci_4_6",
        "name": "Dose Selection Rationale",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "1.6",
        "sectionTitle": "Dose Selection Rationale"
      },
      {
        "id": "nci_7_1",
        "name": "Inclusion Criteria",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.1",
        "sectionTitle": "Inclusion Criteria"
      },
      {
        "id": "nci_7_2",
        "name": "Exclusion Criteria",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.2",
        "sectionTitle": "Exclusion Criteria"
      },
      {
        "id": "nci_7_3",
        "name": "Randomization Criteria",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.3",
        "sectionTitle": "Randomization Criteria"
      },
      {
        "id": "nci_7_4",
        "name": "Lifestyle Requirements",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.4",
        "sectionTitle": "Lifestyle Requirements"
      },
      {
        "id": "nci_7_5",
        "name": "Sponsor’s Qualified Medical Personnel",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "4.5",
        "sectionTitle": "Sponsor’s Qualified Medical Personnel"
      },
      {
        "id": "nci_8_1",
        "name": "Allocation to Treatment",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.1",
        "sectionTitle": "Allocation to Treatment"
      },
      {
        "id": "nci_8_2",
        "name": "Rescue Treatment",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.2",
        "sectionTitle": "Rescue Treatment"
      },
      {
        "id": "nci_8_3",
        "name": "Breaking the Blind",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.3",
        "sectionTitle": "Breaking the Blind"
      },
      {
        "id": "nci_8_4",
        "name": "Subject Compliance",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.4",
        "sectionTitle": "Subject Compliance"
      },
      {
        "id": "nci_8_5",
        "name": "Investigational Product Supplies",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.5",
        "sectionTitle": "Investigational Product Supplies"
      },
      {
        "id": "nci_8_6",
        "name": "Administration",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.6",
        "sectionTitle": "Administration"
      },
      {
        "id": "nci_8_7",
        "name": "Investigational Product Storage",
        "text": "",
        "order": 6,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.7",
        "sectionTitle": "Investigational Product Storage"
      },
      {
        "id": "nci_8_8",
        "name": "Investigational Product Accountability",
        "text": "",
        "order": 7,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.8",
        "sectionTitle": "Investigational Product Accountability"
      },
      {
        "id": "nci_8_9",
        "name": "Concomitant Treatment(s)",
        "text": "",
        "order": 8,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "5.9",
        "sectionTitle": "Concomitant Treatment(s)"
      },
      {
        "id": "nci_9_1",
        "name": "Visit 1, Screening",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.1",
        "sectionTitle": "Visit 1, Screening"
      },
      {
        "id": "nci_9_2",
        "name": "Run-In Induction Treatment Period",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.2",
        "sectionTitle": "Run-In Induction Treatment Period"
      },
      {
        "id": "nci_9_3",
        "name": "Double-Blind Maintenance Treatment Period",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.3",
        "sectionTitle": "Double-Blind Maintenance Treatment Period"
      },
      {
        "id": "nci_9_4",
        "name": "Follow-up Visit",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.4",
        "sectionTitle": "Follow-up Visit"
      },
      {
        "id": "nci_9_5",
        "name": "Rescue Treatment Period",
        "text": "",
        "order": 4,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.5",
        "sectionTitle": "Rescue Treatment Period"
      },
      {
        "id": "nci_9_6",
        "name": "Subject Withdrawal",
        "text": "",
        "order": 5,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "6.6",
        "sectionTitle": "Subject Withdrawal"
      },
      {
        "id": "nci_10_1",
        "name": "Pregnancy Testing",
        "text": "",
        "order": 0,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.1",
        "sectionTitle": "Pregnancy Testing"
      },
      {
        "id": "nci_10_2",
        "name": "Safety Assessments",
        "text": "",
        "order": 1,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.3",
        "sectionTitle": "Safety Assessments"
      },
      {
        "id": "nci_10_3",
        "name": "Skin Type Assessment",
        "text": "",
        "order": 2,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.4",
        "sectionTitle": "Skin Type Assessment"
      },
      {
        "id": "nci_10_4",
        "name": "Assessment of Suicidal Ideation and Behavior",
        "text": "",
        "order": 3,
        "instanceType": "NarrativeContentItem",
        "sectionNumber": "7.5",
        "sectionTitle": "Assessment of Suicidal Ideation and Behavior"
      }
    ],
    "abbreviations": [
      {
        "id": "abbr_1",
        "abbreviatedText": "AD",
        "expandedText": "Atopic Dermatitis",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_2",
        "abbreviatedText": "C-SSRS",
        "expandedText": "Columbia Suicide Severity Rating Scale",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_3",
        "abbreviatedText": "CYP2C19",
        "expandedText": "Cytochrome P450 2C19",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_4",
        "abbreviatedText": "CYP2C9",
        "expandedText": "Cytochrome P450 2C9",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_5",
        "abbreviatedText": "ECs",
        "expandedText": "Ethics Committees",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_6",
        "abbreviatedText": "EOS",
        "expandedText": "End of Study",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_7",
        "abbreviatedText": "EOT/ET",
        "expandedText": "End of Treatment/Early Termination",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_8",
        "abbreviatedText": "EQ-5D-5L",
        "expandedText": "EuroQol 5-Dimension 5-Level",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_9",
        "abbreviatedText": "EQ-5D-Y",
        "expandedText": "EuroQol 5-Dimension Youth",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_10",
        "abbreviatedText": "EudraCT",
        "expandedText": "European Clinical Trials Database",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_11",
        "abbreviatedText": "EU",
        "expandedText": "European Union",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_12",
        "abbreviatedText": "FACIT-F",
        "expandedText": "Functional Assessment of Chronic Illness Therapy-Fatigue",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_13",
        "abbreviatedText": "HBcAb",
        "expandedText": "Hepatitis B core antibody",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_14",
        "abbreviatedText": "HBsAb",
        "expandedText": "Hepatitis B surface antibody",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_15",
        "abbreviatedText": "HBsAg",
        "expandedText": "Hepatitis B surface antigen",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_16",
        "abbreviatedText": "HBV DNA",
        "expandedText": "Hepatitis B virus deoxyribonucleic acid",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_17",
        "abbreviatedText": "IND",
        "expandedText": "Investigational New Drug",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_18",
        "abbreviatedText": "IRBs",
        "expandedText": "Institutional Review Boards",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_19",
        "abbreviatedText": "JAK1",
        "expandedText": "Janus Kinase 1",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_20",
        "abbreviatedText": "LLQ",
        "expandedText": "Lower limit of quantification",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_21",
        "abbreviatedText": "N/A",
        "expandedText": "Not applicable",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_22",
        "abbreviatedText": "NRS",
        "expandedText": "Numerical Rating Scale",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_23",
        "abbreviatedText": "OTC",
        "expandedText": "Over-the-counter",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_24",
        "abbreviatedText": "Peds-FACIT-F",
        "expandedText": "Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_25",
        "abbreviatedText": "PK",
        "expandedText": "Pharmacokinetics",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_26",
        "abbreviatedText": "PRO",
        "expandedText": "Patient-reported outcome",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_27",
        "abbreviatedText": "QD",
        "expandedText": "Once daily",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_28",
        "abbreviatedText": "SBQ-R",
        "expandedText": "Suicidal Behaviors Questionnaire-Revised",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_29",
        "abbreviatedText": "SF-36",
        "expandedText": "Short Form-36",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_30",
        "abbreviatedText": "TB",
        "expandedText": "Tuberculosis",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_31",
        "abbreviatedText": "US",
        "expandedText": "United States",
        "instanceType": "Abbreviation"
      },
      {
        "id": "abbr_32",
        "abbreviatedText": "VHP",
        "expandedText": "Voluntary Harmonisation Procedure",
        "instanceType": "Abbreviation"
      }
    ],
    "summary": {
      "sectionCount": 10,
      "itemCount": 30,
      "abbreviationCount": 32
    },
    "studyDefinitionDocument": {
      "id": "sdd_1",
      "name": "A PHASE 3 RANDOMIZED WITHDRAWAL, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 IN SUBJECTS AGED 12 YEARS AND OVER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH THE OPTION OF RESCUE TREATMENT IN FLARING SUBJECTS",
      "documentType": "Protocol",
      "language": "en",
      "instanceType": "StudyDefinitionDocument",
      "version": "Amendment 5",
      "versionDate": "28 October 2019",
      "contentIds": [
        "nc_1",
        "nc_2",
        "nc_3",
        "nc_4",
        "nc_5",
        "nc_6",
        "nc_7",
        "nc_8",
        "nc_9",
        "nc_10"
      ]
    }
  },
  "rawResponse": {
    "abbreviations": {
      "abbreviations": [
        {
          "abbreviation": "AD",
          "expansion": "Atopic Dermatitis"
        },
        {
          "abbreviation": "C-SSRS",
          "expansion": "Columbia Suicide Severity Rating Scale"
        },
        {
          "abbreviation": "CYP2C19",
          "expansion": "Cytochrome P450 2C19"
        },
        {
          "abbreviation": "CYP2C9",
          "expansion": "Cytochrome P450 2C9"
        },
        {
          "abbreviation": "ECs",
          "expansion": "Ethics Committees"
        },
        {
          "abbreviation": "EOS",
          "expansion": "End of Study"
        },
        {
          "abbreviation": "EOT/ET",
          "expansion": "End of Treatment/Early Termination"
        },
        {
          "abbreviation": "EQ-5D-5L",
          "expansion": "EuroQol 5-Dimension 5-Level"
        },
        {
          "abbreviation": "EQ-5D-Y",
          "expansion": "EuroQol 5-Dimension Youth"
        },
        {
          "abbreviation": "EudraCT",
          "expansion": "European Clinical Trials Database"
        },
        {
          "abbreviation": "EU",
          "expansion": "European Union"
        },
        {
          "abbreviation": "FACIT-F",
          "expansion": "Functional Assessment of Chronic Illness Therapy-Fatigue"
        },
        {
          "abbreviation": "HBcAb",
          "expansion": "Hepatitis B core antibody"
        },
        {
          "abbreviation": "HBsAb",
          "expansion": "Hepatitis B surface antibody"
        },
        {
          "abbreviation": "HBsAg",
          "expansion": "Hepatitis B surface antigen"
        },
        {
          "abbreviation": "HBV DNA",
          "expansion": "Hepatitis B virus deoxyribonucleic acid"
        },
        {
          "abbreviation": "IND",
          "expansion": "Investigational New Drug"
        },
        {
          "abbreviation": "IRBs",
          "expansion": "Institutional Review Boards"
        },
        {
          "abbreviation": "JAK1",
          "expansion": "Janus Kinase 1"
        },
        {
          "abbreviation": "LLQ",
          "expansion": "Lower limit of quantification"
        },
        {
          "abbreviation": "N/A",
          "expansion": "Not applicable"
        },
        {
          "abbreviation": "NRS",
          "expansion": "Numerical Rating Scale"
        },
        {
          "abbreviation": "OTC",
          "expansion": "Over-the-counter"
        },
        {
          "abbreviation": "Peds-FACIT-F",
          "expansion": "Pediatric Functional Assessment of Chronic Illness Therapy-Fatigue"
        },
        {
          "abbreviation": "PK",
          "expansion": "Pharmacokinetics"
        },
        {
          "abbreviation": "PRO",
          "expansion": "Patient-reported outcome"
        },
        {
          "abbreviation": "QD",
          "expansion": "Once daily"
        },
        {
          "abbreviation": "SBQ-R",
          "expansion": "Suicidal Behaviors Questionnaire-Revised"
        },
        {
          "abbreviation": "SF-36",
          "expansion": "Short Form-36"
        },
        {
          "abbreviation": "TB",
          "expansion": "Tuberculosis"
        },
        {
          "abbreviation": "US",
          "expansion": "United States"
        },
        {
          "abbreviation": "VHP",
          "expansion": "Voluntary Harmonisation Procedure"
        }
      ]
    },
    "structure": {
      "document": {
        "title": "A PHASE 3 RANDOMIZED WITHDRAWAL, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 IN SUBJECTS AGED 12 YEARS AND OVER, WITH MODERATE TO SEVERE ATOPIC DERMATITIS WITH THE OPTION OF RESCUE TREATMENT IN FLARING SUBJECTS",
        "version": "Amendment 5",
        "versionDate": "28 October 2019"
      },
      "sections": [
        {
          "number": "N/A",
          "title": "PROTOCOL SUMMARY",
          "type": "Synopsis"
        },
        {
          "number": "N/A",
          "title": "SCHEDULE OF ACTIVITIES FOR RUN-IN AND BLINDED TREATMENTS",
          "type": "Study Procedures"
        },
        {
          "number": "N/A",
          "title": "SCHEDULE OF ACTIVITIES FOR RESCUE TREATMENT – FLARE AT SCHEDULED OR UNSCHEDULED VISIT",
          "type": "Study Procedures"
        },
        {
          "number": "1",
          "title": "INTRODUCTION",
          "type": "Introduction",
          "subsections": [
            {
              "number": "1.1",
              "title": "Mechanism of Action/Indication"
            },
            {
              "number": "1.2",
              "title": "Background and Rationale"
            },
            {
              "number": "1.3",
              "title": "Summary of PF-04965842 Clinical Pharmacokinetics"
            },
            {
              "number": "1.4",
              "title": "Population Pharmacokinetics"
            },
            {
              "number": "1.5",
              "title": "Summary of Benefits and Risks"
            },
            {
              "number": "1.6",
              "title": "Dose Selection Rationale"
            }
          ]
        },
        {
          "number": "2",
          "title": "STUDY OBJECTIVES AND ENDPOINTS",
          "type": "Objectives"
        },
        {
          "number": "3",
          "title": "STUDY DESIGN",
          "type": "Study Design"
        },
        {
          "number": "4",
          "title": "SUBJECT ELIGIBILITY CRITERIA",
          "type": "Eligibility Criteria",
          "subsections": [
            {
              "number": "4.1",
              "title": "Inclusion Criteria"
            },
            {
              "number": "4.2",
              "title": "Exclusion Criteria"
            },
            {
              "number": "4.3",
              "title": "Randomization Criteria"
            },
            {
              "number": "4.4",
              "title": "Lifestyle Requirements"
            },
            {
              "number": "4.5",
              "title": "Sponsor’s Qualified Medical Personnel"
            }
          ]
        },
        {
          "number": "5",
          "title": "STUDY TREATMENTS",
          "type": "Treatment",
          "subsections": [
            {
              "number": "5.1",
              "title": "Allocation to Treatment"
            },
            {
              "number": "5.2",
              "title": "Rescue Treatment"
            },
            {
              "number": "5.3",
              "title": "Breaking the Blind"
            },
            {
              "number": "5.4",
              "title": "Subject Compliance"
            },
            {
              "number": "5.5",
              "title": "Investigational Product Supplies"
            },
            {
              "number": "5.6",
              "title": "Administration"
            },
            {
              "number": "5.7",
              "title": "Investigational Product Storage"
            },
            {
              "number": "5.8",
              "title": "Investigational Product Accountability"
            },
            {
              "number": "5.9",
              "title": "Concomitant Treatment(s)"
            }
          ]
        },
        {
          "number": "6",
          "title": "STUDY PROCEDURES",
          "type": "Study Procedures",
          "subsections": [
            {
              "number": "6.1",
              "title": "Visit 1, Screening"
            },
            {
              "number": "6.2",
              "title": "Run-In Induction Treatment Period"
            },
            {
              "number": "6.3",
              "title": "Double-Blind Maintenance Treatment Period"
            },
            {
              "number": "6.4",
              "title": "Follow-up Visit"
            },
            {
              "number": "6.5",
              "title": "Rescue Treatment Period"
            },
            {
              "number": "6.6",
              "title": "Subject Withdrawal"
            }
          ]
        },
        {
          "number": "7",
          "title": "ASSESSMENTS",
          "type": "Assessments",
          "subsections": [
            {
              "number": "7.1",
              "title": "Pregnancy Testing"
            },
            {
              "number": "7.3",
              "title": "Safety Assessments"
            },
            {
              "number": "7.4",
              "title": "Skin Type Assessment"
            },
            {
              "number": "7.5",
              "title": "Assessment of Suicidal Ideation and Behavior"
            }
          ]
        }
      ]
    }
  }
}